Topical treatment of atopic dermatitis: a clinical case
- Authors: Kuvshinova E.D1
-
Affiliations:
- Federal Research Center for Nutrition, Biotechnology and Food Safety
- Issue: Vol 27, No 1 (2020)
- Pages: 92-96
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312492
- DOI: https://doi.org/10.18565/pharmateca.2020.1.92-95
- ID: 312492
Cite item
Open Access
Access granted
Abstract
Background. Atopic dermatitis (AtD) - is one of the common chronic allergic inflammatory skin diseases, which is accompanied by itching and age-related morphology of the elements. Genetic and immune mechanisms are involved in the development of the disease. The article presents modern approaches to the topical therapy of AtD. The place of traditional drugs, topical glucocorticosteroids, medicinal cosmetics in the treatment of AtD is considered. Description of the clinical case. A case of severe AtD in 6-month-old child is presented. Complex treatment of AtD, including a personalized diet, the use of medications and topical therapy (glucocorticosteroids, skin care products), made it possible to control the course of the disease and reduce the risk of relapse. Conclusion. Daily use of medicinal cosmetics significantly increases the effectiveness of the complex treatment of AtD and improves the quality of life of patients.
Full Text
About the authors
E. D Kuvshinova
Federal Research Center for Nutrition, Biotechnology and Food Safety
Email: len.kuwshinowa@yandex.ru
PhD, Senior Researcher at the Department of Allergology 2/14, build. 1, Ustinsky passage, Moscow 109240, Russian Federation
References
- Аллергология и иммунология: национальное руководство / Под ред. Р.М. Хаитова, Н.И. Ильиной. М.: ГЭОТАР-Медиа, 2009. 656 с
- Ревякина В.А. Этапная терапия атопического дерматита у детей. Consilium Medicum. Педиатрия. 2015;1:50-3
- Shaker M. New insights into the allergic march. Curr Opin Pediatr. 2014;26(4):516-20. doi: 10.1097/M0P0000000000000120.
- Hae-Jin L, Seung-Hun L. Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res. 2014;6(4):276-87. Doi: 10.4168/ aair.2014.6.4.276.
- Bouwstra J.A, Pilgrim K., Ponec M., Elias M.K.,Feingold R. Structure of the skin barrier, in Skin barrier. New York: Naylor and Francis, 2006. 65 p.
- Gork M.J. Epidermal barrier, dysfunction in in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892-908. doi: 10.1038/jid.2009.133.
- Ревякина В.А., Таганов А.В., Кувшинова Е.Д. и др. Атопический дерматит, современная стратегия в терапии. Лечащий врач. 2019;5:32-7.
- Клиническая аллергология и иммунология: руководство для практикующих врачей / Под ред. Л.А. Горячкиной, К.П. Кашкина. М., 2009. 432 с
- Gallen A. Systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156(2):203-21. Doi: https:// doi
- Дерматология. Национальное руководство. Краткое издание. М., 2013. 896 с
- Grimalt R., Mengeaud V, Cambazard F. The steroidsparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007;214(1):61-7.
- Ларькова И.А., Ревякина В.А., Кравцова П.О., Кувшинова Е.Д. Современные средства ухода за кожей в базисной терапии атопического дерматита. Consilium Medicum. Педиатрия. 2017;1:86-8.
Supplementary files
